Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
221.1
USD
|
+0.60%
|
|
+1.35%
|
+11.47%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
55,628
|
61,759
|
67,226
|
41,460
|
56,557
|
63,215
|
-
|
-
|
Enterprise Value (EV)
1 |
61,796
|
67,185
|
75,624
|
49,441
|
63,820
|
69,891
|
69,470
|
68,984
|
P/E ratio
|
36.2
x
|
-51.5
x
|
60
x
|
38.2
x
|
41.4
x
|
35.1
x
|
30.7
x
|
26.9
x
|
Yield
|
0.96%
|
0.87%
|
0.83%
|
1.42%
|
1.09%
|
1.03%
|
1.1%
|
1.23%
|
Capitalization / Revenue
|
3.73
x
|
5.24
x
|
5.28
x
|
2.92
x
|
3.69
x
|
3.94
x
|
3.74
x
|
3.54
x
|
EV / Revenue
|
4.15
x
|
5.7
x
|
5.94
x
|
3.48
x
|
4.17
x
|
4.36
x
|
4.11
x
|
3.87
x
|
EV / EBITDA
|
19.1
x
|
27.6
x
|
28.6
x
|
18.2
x
|
20.9
x
|
20
x
|
18.2
x
|
16.6
x
|
EV / FCF
|
38.1
x
|
49.8
x
|
53.3
x
|
46
x
|
39
x
|
38.3
x
|
34.5
x
|
31
x
|
FCF Yield
|
2.62%
|
2.01%
|
1.88%
|
2.18%
|
2.57%
|
2.61%
|
2.9%
|
3.23%
|
Price to Book
|
6.4
x
|
10.1
x
|
9.3
x
|
5.77
x
|
7.06
x
|
7.28
x
|
6.73
x
|
6.25
x
|
Nbr of stocks (in thousands)
|
288,244
|
285,445
|
286,567
|
284,828
|
285,140
|
285,912
|
-
|
-
|
Reference price
2 |
193.0
|
216.4
|
234.6
|
145.6
|
198.4
|
221.1
|
221.1
|
221.1
|
Announcement Date
|
2/18/20
|
2/16/21
|
2/15/22
|
2/14/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
14,906
|
11,790
|
12,733
|
14,188
|
15,320
|
16,048
|
16,913
|
17,843
|
EBITDA
1 |
3,237
|
2,436
|
2,642
|
2,712
|
3,050
|
3,503
|
3,809
|
4,150
|
EBIT
1 |
2,264
|
1,624
|
1,799
|
1,773
|
2,126
|
2,515
|
2,796
|
3,112
|
Operating Margin
|
15.19%
|
13.77%
|
14.13%
|
12.5%
|
13.88%
|
15.67%
|
16.53%
|
17.44%
|
Earnings before Tax (EBT)
1 |
1,899
|
1,161
|
1,414
|
1,343
|
1,756
|
2,283
|
2,556
|
2,716
|
Net income
1 |
1,559
|
-1,205
|
1,130
|
1,092
|
1,372
|
1,802
|
2,049
|
2,295
|
Net margin
|
10.46%
|
-10.22%
|
8.87%
|
7.69%
|
8.96%
|
11.23%
|
12.12%
|
12.86%
|
EPS
2 |
5.330
|
-4.200
|
3.910
|
3.810
|
4.790
|
6.291
|
7.210
|
8.232
|
Free Cash Flow
1 |
1,620
|
1,350
|
1,419
|
1,076
|
1,637
|
1,825
|
2,015
|
2,226
|
FCF margin
|
10.87%
|
11.45%
|
11.14%
|
7.58%
|
10.69%
|
11.37%
|
11.91%
|
12.48%
|
FCF Conversion (EBITDA)
|
50.05%
|
55.4%
|
53.71%
|
39.67%
|
53.68%
|
52.08%
|
52.88%
|
53.65%
|
FCF Conversion (Net income)
|
103.93%
|
-
|
125.58%
|
98.53%
|
119.29%
|
101.25%
|
98.32%
|
97.02%
|
Dividend per Share
2 |
1.850
|
1.890
|
1.950
|
2.060
|
2.160
|
2.272
|
2.422
|
2.722
|
Announcement Date
|
2/18/20
|
2/16/21
|
2/15/22
|
2/14/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
3,321
|
3,365
|
3,267
|
3,581
|
3,669
|
3,671
|
3,572
|
3,852
|
3,958
|
3,938
|
3,742
|
4,029
|
4,145
|
4,163
|
3,973
|
EBITDA
1 |
731.9
|
690.7
|
566.2
|
665.8
|
740.7
|
738.9
|
613.6
|
743.7
|
838
|
855
|
777.7
|
856.8
|
934.1
|
940.5
|
850.8
|
EBIT
1 |
525
|
475.1
|
331.5
|
431.1
|
507.9
|
502.4
|
379.3
|
513.8
|
608.6
|
624.5
|
533.7
|
609.5
|
681.3
|
687.7
|
604
|
Operating Margin
|
15.81%
|
14.12%
|
10.15%
|
12.04%
|
13.84%
|
13.68%
|
10.62%
|
13.34%
|
15.38%
|
15.86%
|
14.26%
|
15.13%
|
16.44%
|
16.52%
|
15.2%
|
Earnings before Tax (EBT)
1 |
402.4
|
349.5
|
220.3
|
389.3
|
412.2
|
321.6
|
290.5
|
421.3
|
506.2
|
537.5
|
479
|
546.4
|
619.4
|
624.7
|
557
|
Net income
1 |
324.5
|
301
|
171.9
|
308.3
|
347.1
|
264.4
|
233.4
|
329.7
|
404
|
405.2
|
372.9
|
433.7
|
494
|
500.7
|
438.9
|
Net margin
|
9.77%
|
8.95%
|
5.26%
|
8.61%
|
9.46%
|
7.2%
|
6.53%
|
8.56%
|
10.21%
|
10.29%
|
9.96%
|
10.76%
|
11.92%
|
12.03%
|
11.05%
|
EPS
2 |
1.120
|
1.040
|
0.6000
|
1.080
|
1.210
|
0.9300
|
0.8200
|
1.150
|
1.410
|
1.410
|
1.291
|
1.514
|
1.729
|
1.755
|
1.535
|
Dividend per Share
2 |
0.4800
|
0.5100
|
0.5100
|
0.5100
|
0.5100
|
0.5300
|
0.5300
|
0.5300
|
-
|
0.5700
|
0.5544
|
0.5617
|
0.5659
|
0.5798
|
0.5491
|
Announcement Date
|
10/26/21
|
2/15/22
|
4/26/22
|
7/26/22
|
11/1/22
|
2/14/23
|
5/2/23
|
8/1/23
|
10/31/23
|
2/13/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,168
|
5,426
|
8,398
|
7,982
|
7,262
|
6,676
|
6,255
|
5,769
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.905
x
|
2.227
x
|
3.179
x
|
2.944
x
|
2.381
x
|
1.906
x
|
1.642
x
|
1.39
x
|
Free Cash Flow
1 |
1,620
|
1,350
|
1,419
|
1,076
|
1,637
|
1,825
|
2,015
|
2,226
|
ROE (net income / shareholders' equity)
|
20.4%
|
15.7%
|
16.9%
|
15.1%
|
18%
|
21.4%
|
22.7%
|
23.7%
|
ROA (Net income/ Total Assets)
|
8.32%
|
5.98%
|
5.75%
|
5.12%
|
6.34%
|
8.1%
|
8.88%
|
9.53%
|
Assets
1 |
18,738
|
-20,157
|
19,666
|
21,335
|
21,655
|
22,252
|
23,086
|
24,082
|
Book Value Per Share
2 |
30.10
|
21.50
|
25.20
|
25.20
|
28.10
|
30.40
|
32.90
|
35.40
|
Cash Flow per Share
2 |
8.280
|
6.410
|
7.130
|
6.240
|
8.420
|
9.080
|
14.10
|
25.70
|
Capex
1 |
801
|
489
|
643
|
713
|
775
|
807
|
844
|
896
|
Capex / Sales
|
5.37%
|
4.15%
|
5.05%
|
5.02%
|
5.06%
|
5.03%
|
4.99%
|
5.02%
|
Announcement Date
|
2/18/20
|
2/16/21
|
2/15/22
|
2/14/23
|
2/13/24
|
-
|
-
|
-
|
Last Close Price
221.1
USD Average target price
231.8
USD Spread / Average Target +4.83% Consensus |
1st Jan change
|
Capi.
|
---|
| +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B | | +35.12% | 12.81B |
Other Specialty Chemicals
|